Goldman Sachs raised the firm’s price target on Cognex (CGNX) to $70 from $68 and keeps a Buy rating on the shares as part of a broader research note previewing Q1 results among multi-industry names. The firm notes that the market is under-appreciating the company’s $35-$40M annualized operating expense reduction plan for 2026, which should support strong earnings absent any changes to end market trends, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CGNX:
